Machine learning identifies lncRNA drivers of cancer progression in Chronic Lymphocytic Leukemia and Prostate Adenocarcinoma, suggesting novel biological insights.
Long non-coding RNAs (lncRNAs) regulate gene expression through chromatin remodeling, transcriptional control, and posttranscriptional modulation, influencing physiological cell homeostasis but also disease onset. Yet most transcriptomic and network-based studies rely on descriptive linear co-expression analyses, missing nonlinear and mechanistic insights. Emerging ML/DL methods offer promise but remain limited by data sparsity, noise, insufficient biological priors, and poor interpretability, constraining systems level lncRNA-mRNA motif discovery. In this manuscript, we introduce lncAPNet, an extended version of APNet workflow, which integrates graph based nonlinear inference of lncRNA and mRNA interactions using NetBID2 activity logic within an lncRNA focused SJARACNe coexpression network, coupled with PASNet, a biologically informed sparse deep learning model. This framework enables explainable identification of lncRNA drivers in two different cancer type case studies, Chronic Lymphocytic Leukemia (CLL) and Prostate Adenocarcinoma (PRAD), uncovering lncRNA drivers that illuminate lncRNA mediated programs in cancer progression.
No takes yet. Share an insight, caveat, or question.
Vasileiou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: